- Intravesical chemotherapy in patients with NMIBC2022 | First Faculty of Medicine
- Assessing the impact of BCG on progression of NMIBC in the new EAU high risk and very high-risk groupsPublication without faculty affiliation
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel2021 | First Faculty of Medicine, Second Faculty of Medicine
- Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer2020 | Second Faculty of Medicine
- Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective2022 | Second Faculty of Medicine
- Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis2023 | Second Faculty of Medicine
- Tumors of the urinary bladder2012 | Second Faculty of Medicine
- A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment after Transurethral Resection2021 | Second Faculty of Medicine
- Impact of Preoperative Serum Albumin-Globulin Ratio on Disease Outcome After Radical Cystectomy for Urothelial Carcinoma of the Bladder2021 | Second Faculty of Medicine
- En bloc resection of bladder tumour: the rebirth of past through reminiscence2023 | Second Faculty of Medicine
- KARCINOM MOČOVÉHO MĚCHÝŘE: DOPORUČENÉ POSTUPY V LOKÁLNÍ TERAPII A OPERATIVĚPublication without faculty affiliation
- EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder - the 2011 Update2011 | Second Faculty of Medicine
- Immunotherapy in the bladder cancer treatment: long-term results2020 | Faculty of Medicine in Hradec Králové
- Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study2022 | Second Faculty of Medicine
- Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review2017 | First Faculty of Medicine, Second Faculty of Medicine
- En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?2020 | Second Faculty of Medicine
- Should a Second Transurethral Resection Be Performed in All Patients with T1 or High-Grade Non-Muscle-Invasive Bladder Cancer?2011 | Second Faculty of Medicine
- What to do during Bacillus Calmette-Guerin shortage? Valid strategies based on evidence2018 | Second Faculty of Medicine
- Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy2023 | Second Faculty of Medicine
- Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group2022 | Second Faculty of Medicine
- Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey2019 | Second Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | First Faculty of Medicine, Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder2013 | Second Faculty of Medicine
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update2019 | First Faculty of Medicine, Second Faculty of Medicine
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 20162017 | First Faculty of Medicine, Second Faculty of Medicine
- Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer2013 | Second Faculty of Medicine
- Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review2020 | Second Faculty of Medicine
- Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature2012 | Second Faculty of Medicine
- Prognostic value of clinico-pathological factors in patiens with TAT1 baldder carcinoma2011 | First Faculty of Medicine